Manufacturers Life Insurance Company, The Surface Oncology, Inc. Transaction History

Manufacturers Life Insurance Company, The

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.42 - $3.15 $14,790 - $32,810	-10,416 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$2.65 - $5.08 $27,602 - $52,913	10,416 New	10,416 $30,000
Q1 2022 May 20, 2022	SELL	$2.65 - $5.08 $18,277 - $35,036	-6,897 Reduced 39.84%	10,416 $31,000
Q4 2021 Feb 16, 2022	SELL	$4.73 - $7.9 $20,769 - $34,688	-4,391 Reduced 20.23%	17,313 $83,000
Q3 2021 Nov 12, 2021	BUY	$5.16 - $7.98 $111,992 - $173,197	21,704 New	21,704 $164,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.